APPENDIX IV OECD GUIDELINES FOR TESTING OF CHEMICALS. 1- The OECD Test Guidelines submission and adoption process
|
|
- Gyles Horton
- 5 years ago
- Views:
Transcription
1 APPENDIX IV OECD GUIDELINES FOR TESTING OF CHEMICALS 1- The OECD Test Guidelines submission and adoption process The OECD Test Guidelines Programme provides the mechanism for developing new Test Guidelines, and/or updating existing Guidelines. OECD Test Guidelines are broadly accepted by the international scientific community and by appropriate regulatory authorities of OECD Member countries and a number of Non-Member countries. The Joint Meeting of the Chemicals Committee and Working Party on Chemicals, Pesticides and Biotechnology (the Joint Meeting) is the OECD policy body that oversees the implementation of the Test Guidelines Programme. The Joint Meeting reviews and endorses draft Test Guidelines, and builds consensus to overcome policy differences that would otherwise jeopardise progress in Test Guideline development. A pivotal role in this Programme has been assigned to the Working Group of National Co-ordinators of the Test Guidelines Programme (WNT). The European Commission (EC) participates in this group, along with the National Co-ordinators from Member countries as appointed by their respective National Delegations to the Joint Meeting. Other invited experts also participate, as agreed by the Joint Meeting. The WNT considers proposals for new and updated Guidelines for the work programme and prioritises such proposals. The WNT meets yearly, usually in late May or early June. Any proposal to develop a new, or update an existing, Test Guideline should include a critical appraisal concerning its scientific justification, its sensitivity, and its reproducibility. New methods, and existing Test Guidelines for which major revisions are proposed, should be validated as appropriate prior to their adoption. The process of validation is flexible, but transparency is essential. Proposals to develop new or updated Test Guidelines should be supported by valid arguments, which explain that there is a need for such a new or updated, supported by regulatory arguments. These should include at least one of the following; That the proposal will achieve further progress in international harmonization of datarequirements; That scientific arguments indicate the importance of the or the modifications; That the proposal addresses issues and/or endpoints which are of major human health or environmental concern. That there are animal welfare advantages to the proposed /procedure with respect to the 3R s(replacement, reduction and refinement) without loss of essential information; That the proposed /procedure will result in reduced cost without loss of essential information. When there is a recognised need for new or updated Test Guidelines, the development/update of these Test Guidelines, as part of the overall work programme approved by the Joint Meeting, can be realised in one of two ways: (i), by beginning with a Detailed Review Paper of the area concerned or, when a particular method has not yet emerged as the preferred one, (ii) by drafting a Test Guideline proposal
2 When a new/revised is developed sufficiently to be proposed as an OECD Test Guideline, submission to the OECD Secretariat may be done by any of the following processes: a Member country, or the European Commission, through its National Co-ordinator; industry, trade unions, environmental citizen organisations, and animal protection organisations through their representative invited experts on the WNT Detailed information about the basis for the and its performance should be documented and available for review, including the validation study reports, any specific data requested by the validation management group, and the peer review report. Details of the process for adopting a method as an OECD Test Guideline are provided in a separate Guidance Document (OECD (1995), which is currently under review. If the draft Test Guideline proposal meets the OECD criteria, it is submitted to the National Coordinators for their review. Through the WNT, National Experts review the proposals for technical content and policy issues such as animal welfare, cost effectiveness and consistency with national regulatory requirements. National Co-ordinators consider the comments from their National Experts and submit National Positions on the proposals. After consensus is reached among Member countries, draft Test Guideline proposals are approved by the WNT, either at the WNT meeting or by written procedure. These proposals are forwarded to the Joint Meeting for their review and endorsement. The Joint Meeting is held about every eight months. A draft Test Guideline rejected by the Joint Meeting will be referred back to the WNT for their reconsideration, together with the reason for its rejection. After the Joint Meeting endorses a new or revised Test Guideline, the Secretariat submits the Test Guideline proposal to the Environment Policy Committee (EPOC). As part of this process, EPOC is invited to review the draft Test Guidelines proposal, within an agreed timeframe (which should be at least six weeks after submission), and, if appropriate, agree to its submission to the Council for formal adoption. The Secretariat can respond to comments from EPOC in a number of ways, ranging from making straight-forward edits and corrections to the proposal, through to referring the comments to the WNT, in which case the modified proposal will again be submitted to the Joint Meeting and EPOC for their approval and endorsement. When any EPOC issues have been resolved, the Secretariat submits the draft Test Guideline Proposal, together with a summary of its rationale and political/social implications for Member countries, to the Council with the request to adopt the Test Guideline under the written procedure. Test Guidelines adopted by the Council become effective from the date of Council adoption. The Secretariat then arranges for publication at the earliest possible date. The total time period from submission of a draft Test Guideline proposal to the formal adoption by Council of a new or updated Test Guideline varies. In cases where well-written draft proposals fulfil the general OECD requirements for a new or updated Test Guideline, and are accompanied by the necessary background documentation (including documented validation study, independent peer review), the period from submission to adoption can be within 18 months. Proposals that are less well developed and supported take a longer the time period, dependent upon the number of iterations required by the WNT and/or Joint Meeting, and the complexity of the issues to be resolved.
3 2- Overview of currently available and draft guidelines of Section 4- Health Effects Original adoption date and the most recent updates together with improvements considering the 3R: reduction, refinement and replacement. The list also covers the la drafts and their status and is divided into two sections; short and long-term toxicology ing and genetic toxicology ing. OECD Guidelines on Short and Long Term Toxicology Testing TG No. Title Original A d o p t i o n Most Recently Updated 401 Acute Oral Toxicity 12 May 1981 Date of Deletion: 20 December Acute Dermal Toxicity 12 May February 1987: Animal (Reduction method) compared to the original TG from 1981, lowering of the dose level 403 Acute Inhalation Toxicity 12 May 1981 Animal 404 Acute Dermal Irritation/Corrosion 405 Acute Eye Irritation/Corrosion 12 May April 2002: Animal (Refinement/reduction tiered ing strategy regarding the original OECD TG), including in vitro screens 12 May April 2002: Animal ; (Refinement/reduction tiered ing strategy regarding the original OECD TG),including in vitro screens, 406 Skin Sensitisation 12 May July 1992: : Animal (Reduction method by 50% compared to original OECD TG) 407 Repeated Dose 28-Day Oral Toxicity Study in Rodents 408 Repeated Dose 90-Day Oral Toxicity Study in Rodents 409 Repeated Dose 90-Day Oral Toxicity Study in Non- 12 May July 1995: Animal (Refinement method compared to original OECD TG)more information on best dosing practice, more information from the same animal. 12 May September 1998: Animal 12 May September 1998: Animal
4 Rodents 410 Repeated Dose Dermal Toxicity: 28-Day 411 Subchronic Dermal Toxicity: 90-Day 412 Repeated Dose Inhalation Toxicity: 28/14-Day 413 Subchronic Inhalation Toxicity: 90-Day 414 Prenatal Developmental Toxicity Study 12 May 1981 Animal 12 May 1981 Animal 12 May 1981 Animal 12 May 1981 Animal 12 May January 2001: Animal (Reduction method regarding the original OECD TG) [use (-20% animals), more information from the same animal] 26 May 1983 Animal 415 One-Generation Reproduction Toxicity 416 Two-generation 26 May January 2001: Reproduction Toxicity Study Animal 417 Toxicokinetics 4 April 1984 Animal 418 Delayed Neurotoxicity of 4 April July 1995: Animal Organophosphorus Substances Following Acute Exposure 419 Delayed Neurotoxicity of Organophosphorus Substances:28-Day Repeated Dose Study 420 Acute Oral toxicity Fixed Dose Procedure (FDP) 421 Reproduction/Developmental Toxicity Screening Test 422 Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test 4 April July 1995: Animal 17 July December 2001: Animal (Reduction, refinement method regarding the conventional TG 401). Less suffering, smaller number of animals 27 July 1995 Animal (reduction method compared to original TGs) New Screening provides essential information with a minimum number of animals. 22 March 1996 Animal (reduction method compared to the individual TGs). Combines the new screening on reproduction toxicity with TG 407 and
5 423 Acute Oral Toxicity Acute Toxic Class Method (ATC) 424 Neurotoxicity Study in Rodents 425 Acute Oral Toxicity: Up-and- Down Procedure 426 Developmental Neurotoxicity Study 427 Skin Absorption: In vivo method 428 Skin absorption: In vitro method 429 Skin Sensitisation: Local Lymph Node Assay 430 In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test (TER) 431 In Vitro Skin Corrosion: Human Skin Model Test further reduces the number of animals to an absolute minimum for these combined endpoints. 22 March December 2001 Animal (Reduction method regarding the conventional TG 401). Much smaller number of animals (10% of TG 401) 21 July 1997 Animal 21 September1998 Draft New Guideline (April 2004) (April 2004) 17 December 2001: Animal (Reduction method regarding the conventional TG 401). Smaller number of animals, provides a closer estimate of the LD50 than TG s 420 and 423 Animal Submitted to Council for adoption. Animal Submitted to Council for adoption. True alternative to the in vivo method. Full replacement over the TG April 2002 Animal (Reduction / refinement method regarding TG 406) allowing more information and less suffering. (April 2004) (April 2004) Submitted to Council for adoption. Nonanimal (Replacement method over the corrosion part of TG 404) Submitted to Council for adoption. Nonanimal (Replacement method over the corrosion
6 part of TG 404) 432 In Vitro 3T3 NRU phototoxicity (April 2004) Submitted to Council for adoption. Nonanimal. Full replacement (no OECD TG existed for animal ) 433 Acute Inhalation Toxicity: Fixed Dose Procedure (FDP) Draft New Guideline Animal (Reduction, refinement method regarding TG 403). Uses fewer animals and less suffering. 434 Acute Dermal Toxicity: Fixed Dose Procedure (FDP) Draft New Guideline Animal (Reduction, refinement regarding TG 404). Uses fewer animals and less suffering. 435 In Vitro Skin Corrosivity Draft New Guideline Non-animal (replacement method for the corrosion part of TG 404, for specific applications - only applicable to acids & bases) 451 Carcinogenicity Studies 12 May 1981 Animal 452 Chronic Toxicity Studies 12 May 1981 Animal 453 Combined Chronic toxicity/carcinogenicity Studies 12 May 1981 Animal (the combined TG 453 could offer Reduction compared to individual TG TG 471 Bacterial Reverse Mutation Test 472 Genetic Toxicology: Escherichia coli, Reverse Assay 473 In Vitro Mammalian Chromosome Aberration Test 474 Mammalian Erythrocyte Micronucleus Test 453) 26 May July 1997: In vitro for point mutations *. Non animal (part of strategy) 26 May 1983 Date of deletion: 21 July 1997 (Method merged with TG 471) 26 May July 1997: True alternative to the in vivo. Non animal (part of battery, it does not fully replace the in vivo ) 26 May July 1997: Animal (Reduction
7 475 Mammalian Bone Marrow Chromosome Aberration Test 476 In Vitro Mammalian Cell Gene Mutation Test 477 Genetic Toxicology: Sex- Linked Recessive Lethal Test in Drosophilia melanogaster 478 Genetic Toxicology: Rodent dominant Lethal Test 479 Genetic Toxicology: In Vitro Sister Chromatid Exchange assay in Mammalian Cells 480 Genetic Toxicology: Saccharomyces cerevisiae, Gene Mutation Assay 481 Genetic Toxicology: Saccharomyces cerevisiae, Mitotic Recombination Assay 482 Genetic Toxicology: DNA Damage and Repair, Unscheduled DNA Synthesis in Mammalian Cells In Vitro 483 Mammalian Spermatagonial Chromosome Aberration Test 484 Genetic Toxicology: Mouse Spot Test 485 Genetic Toxicology: Mouse Heritable Translocation Assay method compared to 1983 version using a smaller number of animals. 4 April July 1997: Animal 4 April July 1997: In vitro for gene mutations (genetic toxicity)*. Non animal (part of strategy) 4 April 1984 Non-animal (flies= non vertebrates) Note: 86/609 defines animals as any live non-human vertebrates 4 April 1984 Animal In vitro for DNA exchanges between sister chromatids (genetic toxicity) *. Non animal (part of strategy) In vitro for gene mutations in Saccharomyces (genetic toxicity*. Non animal (part of strategy) In vitro for mitotic recombination in Saccharomyces (genetic toxicity*. Non animal (part of strategy) True alternative to the in vivo method for DNA damage. Non animal (part of battery, it does not fully replace thein vivo ) 21 July 1997: Animal Animal Animal
8 486 Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells In Vivo 21 July 1997 Animal All in vitro s on Genetic Toxicology Testing are part of a ing strategy which progresses to animal ing only if necessary (in case of equivocal results)
Testing Methods and Directives
EUROPEAN COMMISSION DIRECTORATE GENERAL - JRC JOINT RESEARCH CENTRE Institute for Health and Consumer Protection Unit: Toxicology and Chemical Substances European Chemicals Bureau D:\My Documents\JR\Tables\OFFJOUR\Listofoj.doc
More informationOur Business. in vitro / in vivo. in vitro / in vivo ADME. in vitro / in vivo. Toxicology. Cell Battery V79. Analytical Services. Service.
GenPharmTox is one of the few CROs who can guarantee the success of our project within the given time framework and on the terms agreed. Dr. Michael Runkel, Apogepha GmbH 3 3 In vitro 3.1. Phototoxicity
More informationEFSA Guidance on the Submission of a. Evaluation: Toxicological data
Committed since 2002 to ensuring that Europe s food is safe EFSA Guidance on the Submission of a Dossier on Food Enzymes for Safety Evaluation: Toxicological data Prof. Karl-Heinz Engel CEF Panel member
More informationROLE OF OECD AND THE TEST GUIDELINES PROGRAMME IN THE REGULATORY ACCEPTANCE OF ALTERNATIVE METHODS
ROLE OF OECD AND THE TEST GUIDELINES PROGRAMME IN THE REGULATORY ACCEPTANCE OF ALTERNATIVE METHODS Anne Gourmelon Principal Administrator OECD Test Guidelines Programme Environmental, Health and Safety
More informationThree recently approved in vivo genotoxicity test guidelines
Three recently approved in vivo genotoxicity test guidelines (Revised in February 2018) a. Title of the test guideline (year of original adoption, year of update) In Vitro Mammalian Cell Gene Mutation
More informationTable 1: Current status of the test guidelines for genetic toxicology
OECD TEST GUIDELINES FOR TESTING OF CHEMICALS: INTRODUCTION TO THE OECD GUIDELINES ON GENETIC TOXICOLOGY TESTING 1. GENERAL INTRODUCTION 1. This Introduction to the Test Guidelines (TG) on genetic toxicology
More informationPROPOSAL THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS
THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS PROPOSAL FOR A STRATEGY FOR TESTING HAIR DYE COSMETIC INGREDIENTS FOR THEIR POTENTIAL GENOTOXICITY/MUTAGENICITY
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EN EN EN EUROPEAN COMMISSION Brussels, 16.9.2010 COM(2010) 480 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Report on the Development, Validation and Legal Acceptance of
More informationMedical Device Testing. Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark
Medical Device Testing Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark Medical device Risk evaluation Efficacy Biocompatibility Clinical testing Pharmaceutical product Preclinical
More informationArchived Content. This content was archived on February 4, 2017.
This content was archived on February 4, 2017. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after
More informationCommitted since 2002 to ensuring that Europe s food is safe. David Gott. Chair & Rapporteur - WG Guidance on Food Additives
Committed since 2002 to ensuring that Europe s food is safe Risk assessment paradigm David Gott Vice-chair chair of the ANS Panel Chair & Rapporteur - WG Guidance on Food Additives Stakeholders workshop
More informationTOXICITY STUDIES. Mr.D.Raju M.Pharm., Lecturer
TOXICITY STUDIES Mr.D.Raju M.Pharm., Lecturer INTRODUCTION A drug is a single substance or mixture of substances used for diagnosis, treatment, mitigation or prevention of disease ; restoring, correcting
More informationStructure and content of an IMPD. What is required for first into man trial?
What is required for first into man? The EU IMPD Thomas Sudhop, MD Scope Structure and content of an IMPD What is required for first into man trial? Only for IMPs that do not have a marketing authorisation
More informationAnimal Use in the Safety Evaluation of Chemicals: Harmonization and Emerging Needs
Animal Use in the Safety Evaluation of Chemicals: Harmonization and Emerging Needs Horst Spielmann Abstract An overview is provided of the legal framework in Europe for the use of experimental animals
More informationUPDATED RECOMMENDED STRATEGY TESTING HAIR DYES FOR THEIR POTENTIAL GENOTOXICITY/MUTAGENICITY/CARCINOGENICITY
THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS UPDATED RECOMMENDED STRATEGY FOR TESTING HAIR DYES FOR THEIR POTENTIAL GENOTOXICITY/MUTAGENICITY/CARCINOGENICITY
More informationInconsistencies in data requirements of EU legislation involving tests on animals
Inconsistencies in data requirements of EU legislation involving tests on animals Dipl. Biol. Kristina Wagner Scientific officer for alternatives to animal experiments Animal Welfare Academy, Neubiberg
More informationNational Health Surveillance System (SNVS)
November 19 th, 2014 The National Health Surveillance System National Health Surveillance System (SNVS) Integrates the Unified Health System (SUS) Integrated by the Federal, State and Local level Coordinated
More informationGenotoxicity testing strategies: updated recommendations for the assessment of pesticides Riccardo Crebelli
New Pesticide Regulation: Innovative Aspects and Emerging Problems October 5, 2010 Aula Pocchiari - Istituto Superiore di Sanità Viale Regina Elena, 299 ROMA Genotoxicity testing strategies: updated recommendations
More information(Notices) EUROPEAN COMMISSION
3.4.2013 Official Journal of the European Union C 95/1 IV (Notices) NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Commission Communication in the framework
More informationTest guidelines for regulatory assessment of pesticides and other chemicals in China
2014 International Symposium and Autumn Meeting of the KSPS Test guidelines for regulatory assessment of pesticides and other chemicals in China D r. Cai L e i m i n g ( Z A A S, C H I N A ) M r. C h e
More informationPART B: METHODS FOR THE DETERMINATION OF TOXICITY AND OTHER HEALTH EFFECTS GENERAL INTRODUCTION: PART B A. EXPLANATORY NOTE For the purposes of the
PART B: METHODS FOR THE DETERMINATION OF TOXICITY AND OTHER HEALTH EFFECTS GENERAL INTRODUCTION: PART B A. EXPLANATORY NOTE For the purposes of the General Introduction, the following numbering applies:
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB15193.
Translated English of Chinese Standard: GB15193.1-2003 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA ICS 07.100 C 53 Replacing GB 15193.1-1994
More informationPublic Interest Incorporated Foundation BioSafety Research Center
Public Interest Incorporated Foundation BioSafety Research Center http://www.anpyo.or.jp Ver. 201801 Building #1(Test and research annex) Building #2 (Administrat ion office) Building #3 (Toxicity test
More informationAlternative Testverfahren und intelligente Teststrategien Position der EU-Kommission. Thomas Hartung & ECVAM Team.
Alternative Testverfahren und intelligente Teststrategien Position der EU-Kommission Thomas Hartung & ECVAM Team Institute for Health and Consumer Protection (IHCP) Ispra (Va), Italy http://ecvam.jrc.it
More informationOrganisation de Coopération et de Développement Economiques Organisation for Economic Co-operation and Development
Unclassified ENV/JM/MONO(2006)20/REV1 ENV/JM/MONO(2006)20/REV1 Unclassified Organisation de Coopération et de Développement Economiques Organisation for Economic Co-operation and Development 05-Aug-2009
More informationThe National Health Surveillance System. March 31 st Agência Nacional de Vigilância Sanitária
The National Health Surveillance System Agência Nacional de Vigilância Sanitária March 31 st 2015 www.anvisa.gov.br ANVISA Mission: To promote and protect the population health and to act on the risks
More informationDesign for the Environment Program Criteria for Chelating and Sequestering Agents
Design for the Environment Program Criteria for Chelating and Sequestering Agents Version 1.0 July 2010 Office of Pollution Prevention & Toxics U.S. Environmental Protection Agency Table of Contents 1
More informationGet ready for Meeting your information requirements. 11 th Stakeholder s Day. 25 May 2016
Get ready for 2018 Meeting your information requirements 11 th Stakeholder s Day 25 May 2016 Laurence Hoffstadt, PhD Senior Scientific Officer Evaluation Directorate Key messages It takes time Get organised
More informationSTUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO TESTING
VICH GL33 (SAFETY: GENERAL APPROACH) October 2002 For implementation at Step 7 - Final STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO TESTING Recommended
More informationExpectations of animal welfare organisations in Europe
and 50 Years of the 3Rs Principle Expectations of animal welfare organisations in Europe Roman Kolar Scientific Advisor, Eurogroup for Animals, Brussels Deputy Director, Animal Welfare Academy, Neubiberg
More informationILSI AGRICULTURAL CHEMICAL SAFETY ASSESSMENT (ACSA) PROJECT: A TIERED TESTING APPROACH. November 18, 2005
ILSI AGRICULTURAL CHEMICAL SAFETY ASSESSMENT (ACSA) PROJECT: A TIERED TESTING APPROACH Ann Blacker, PhD, DABT Head of Regulatory Toxicology Bayer CropScience November 18, 2005 HESI ACSA Technical Committee
More informationTechnical Notes for Guidance. on the assessment of technical equivalence of substances regulated under Directive 98/8/EC
Technical Notes for Guidance on the assessment of technical equivalence of substances regulated under Directive 98/8/EC These Technical Notes for Guidance were adopted during the 29 th meeting of representatives
More informationJoint CVMP/CHMP Working group on the Application of the 3Rs in Regulatory Testing of Medical Products
Joint CVMP/CHMP Working group on the Application of the 3Rs in Regulatory Testing of Medical Products Biennial report 2016/2017 Executive summary This report is aimed at informing pharmaceutical companies
More informationGuidance Documents for New Chemical Substance Notification in China (China REACH) Non Official
Guidance Documents for New Chemical Substance Notification in China (China REACH) Non Official On 19 Jan 2010, the Ministry of Environmental Protection (MEP) of China released the revised version (MEP
More informationToxML: A Data Exchange Standard for Toxicology. Dr. MA Ali Senior Scientist, Lhasa Limited
ToxML: A Data Exchange Standard for Toxicology Dr. MA Ali Senior Scientist, Lhasa Limited Contents Background to the ToxML Project Need for a data exchange standard Fundamentals of ToxML Existing exchange
More informationChapter 21. Toxicity Testing
Chapter 21 Toxicity Testing Toxicity Testing There are two purposes of toxicity testing. There is a quantitative effort to elucidate a dose effect relationship There is a qualitative determination of the
More informationOrganisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development
Unclassified ENV/JM/MONO(2016)33 ENV/JM/MONO(2016)33 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 13-Jul-2016 English
More informationToxML: Community Based Development of a Common Data Exchange Standard for Toxicology. Dr. MA Ali Dr. PN Judson
ToxML: Community Based Development of a Common Data Exchange Standard for Toxicology Dr. MA Ali Dr. PN Judson Contents Background to the ToxML Project Need for a data exchange standard Fundamentals of
More informationNB: Unofficial translation; legally binding texts are those in Finnish and Swedish Ministry of the Environment, Finland
NB: Unofficial translation; legally binding texts are those in Finnish and Swedish Ministry of the Environment, Finland Ministry of the Environment Decree on the Applications and Notifications Concerning
More informationAn ASEAN guidance document for evaluating the safety of botanical. [Version ] Botanical Safety Assessment.
ASEAN Cosmetic Scientific Body Botanical Safety Assessment Guidance Document [Version 2014-01] An ASEAN guidance document for evaluating the safety of botanical An ASEAN Guidance document for evaluating
More informationTowards a future of scientific progress without the need for experimental animals: Global trends
Towards a future of scientific progress without the need for experimental animals: Global trends Herman B.W.M.Koëter President, Alternatives Congress Trust Towards a future of scientific progress without
More informationACVM - REGISTRATION STANDARD FOR TOXICOLOGY AND ENVIRONMENTAL TOXICOLOGY
ACVMS 9.1 Ministry of Agriculture and Forestry Post Office Box 2526 WELLINGTON, NEW ZEALAND ACVM - REGISTRATION STANDARD FOR TOXICOLOGY AND ENVIRONMENTAL TOXICOLOGY This document may be altered at any
More informationTesting and Evaluation Strategies for the Biological Evaluation of Medical Devices submitted for CE Mark and FDA Approval
Testing and Evaluation Strategies for the Biological Evaluation of Medical Devices submitted for CE Mark and FDA Approval Today, millions of medical devices are used worldwide to treat or support patients.
More informationMB Expands Capabilities Adds Ames Test, MTD and Range Finding
What's New @ MB? MB Expands Capabilities - Ames, PK, MTD, Range Finding New! - PorCORA - Non-Animal Ocular Irritation/Reversibility Test Under Development - PorFocal - Low-Level Ocular Irritation Screening
More informationAshes (residues), plant
Ashes (residues), plant Information on Dossier according to REACH Regulation Ing. Pavel Donát Belchatów October 2011 Substance Name: Ashes (residues), plant (Biomass Ash) EC number: 297-049-5 CAS number:
More informationData Requirements for New Chemical Notification in China Please go to for more info about China REACH
Data Requirements for New Chemical Notification in China Please go to http://www.cirs-reach.com/ for more info about China REACH Original Article by Chemical Inspection and Regulation Service (CIRS) in
More informationMethod Review by the Interagency Coordinating Committee for the Validation of Alternative Methods (ICCVAM)
Method Review by the Interagency Coordinating Committee for the Validation of Alternative Methods (ICCVAM) ICCVAM was created as an ad-hoc committee in 1994 and became a standing Committee in 2000. ICCVAM
More informationMixture Hazard Assessment Methodology
Mixture Hazard Assessment Methodology March 2018 Written in collaboration with ToxServices LLC Copyright 2017 Cradle to Cradle Products Innovation Institute No part of this publication is to be reproduced
More informationMANUAL FOR INVESTIGATION OF HPV CHEMICALS
MANUAL FOR INVESTIGATION OF HPV CHEMICALS CHAPTER 1: PROCEDURES, INCLUDING THE USE OF THE ELECTRONIC DISCUSSION GROUPS AND THE ON-LINE OECD EXISTING CHEMICALS DATABASE ANNEX 3 : SYNERGIES BETWEEN THE CEPA
More informationUnited States Environmental Protection Agency (EPA) Office of Pesticide Programs (OPP): The Vision for Global Pesticide Reviews
2009/SOM2/SCSC/WKSP2/011 United States Environmental Protection Agency (EPA) Office of Pesticide Programs (OPP): The Vision for Global Pesticide Reviews Submitted by: United States Examination of Hot Issues
More informationLAWSONE OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS. SCCNFP/0561/02, final.
SCCNFP/0561/02, final OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING LAWSONE Colipa n C146 adopted by the SCCNFP during the 19 th plenary
More informationREACH. Innovations under REACH and Challenges for Toxicological Sciences. Martin-Luther-Universität Halle / Saale. MSc Toxikologie Berlin
REACH Innovations under REACH and Challenges for Toxicological Sciences Heidi Foth Martin-Luther-Universität Halle / Saale MSc Toxikologie Berlin 05.11.2008 1 REACH is needed to protect man and environment
More informationGLOBAL CHEMICAL REGISTRATIONS: TESTING STRATEGIES AND CMO COMMUNICATION
GLOBAL CHEMICAL REGISTRATIONS: TESTING STRATEGIES AND CMO COMMUNICATION HPAPI Summit June 21, 2017 Jessica Graham, Ph.D., DABT Senior Research Investigator, Product Quality and Occupational Toxicology
More informationTest compound and controls 1. The test compound or mixture was unlikely to contain any impurities that may significantly have affected its toxicity.
SciRAP criteria and guidance for assessing methodological quality of in vivo toxicity studies The guidance is meant to aid in the evaluation of methodological quality, i.e. design and conduct, of in vivo
More informationRegistration of New Cosmetic Ingredient with SFDA in China
Registration of New Cosmetic Ingredient with SFDA in China Enabling Chemical Compliance for A Safer World 18 April 2012, Yunbo Shi, CIRS China Email: yunbo.shi@cirs-reach.com 1 Table of Contents Legal
More informationRegistration of Proprietary Chinese Medicine!
Registration of Proprietary Chinese Medicine! (Translation from Original Chinese Version) Product Safety Documents Technical Guidelines Table of Contents Page (A) Introduction 3 (B) Brief description of
More informationCHEMICAL SAFETY REPORT. Substance Name: Glucose EC Number: CAS Number: Registrant's Identity: Example Company 1
CHEMICAL SAFETY REPORT Substance Name: Glucose EC Number: 200-075-1 CAS Number: 50-99-7 Registrant's Identity: Example Company 1 Table of Contents Part A... 1 1. SUMMARY OF RISK MANAGEMENT MEASURES...
More informationAn NGO Perspective on Regulatory Acceptance of Non-animal Data and Related Issues. Martin Stephens, Ph.D. The Humane Society of the United States
An NGO Perspective on Regulatory Acceptance of Non-animal Data and Related Issues Martin Stephens, Ph.D. The Humane Society of the United States Animal Use Numbers Rabbits 222,167 Guinea pigs 203,098 Hamsters
More informationTesting of chemicals for classification according to REACH and GHS
Testing of chemicals for classification according to REACH and GHS Norbert Bornatowicz, Head Toxicology Seibersdorf Labor GmbH 2444 Seibersdorf, AUSTRIA Overview on the presentation Classification: IUCLID
More informationSERVA DNA Stain Clear G Cat. No
1 SERVA DNA Stain Clear G Cat. No. 39804 1. Introduction Ethidium bromide (EtBr) is most commonly used nucleic acid stain in molecular biology laboratories. It has been proved to be strong carcinogen and
More informationC.3.9. Repeated Dose Dermal Toxicity: 21/28-Day Study (OECD TG 410)
C.3.9. REPEATED DOSE DERMAL TOXICITY: 21-28-DAY STUDY (OECD TG 410) 557 C.3.9. Repeated Dose Dermal Toxicity: 21/28-Day Study (OECD TG 410) Status: Assay validated by the OECD. 841. Modalities detected:
More informationJSAAE & JaCVAM Joint Workshop International Trends on 3Rs in Animal Experiments 14 February 2011, Tokyo
JSAAE & JaCVAM Joint Workshop International Trends on 3Rs in Animal Experiments 14 February 2011, Tokyo The FP7 Project AXLR8 Accelerating the transition to a toxicity pathway-based paradigm for chemical
More informationTesting of chemicals for classification according to REACH and GHS
Testing of chemicals for classification according to REACH and GHS Norbert Bornatowicz, Head Toxicology Seibersdorf Labor GmbH 2444 Seibersdorf, AUSTRIA Overview on the presentation Classification: IUCLID
More informationREQUEST FOR A RE-EVALUATION OF HAIR DYES LISTED IN ANNEX III TO DIRECTIVE 76/768/EEC ON COSMETIC PRODUCTS
OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING REQUEST FOR A RE-EVALUATION OF HAIR DYES LISTED IN ANNEX III TO DIRECTIVE 76/768/EEC ON
More informationAlternative (Non-animal) Methods for Chemicals Testing: Current Status and Future Prospects
Alternative (Non-animal) Methods for Chemicals Testing: Current Status and Future Prospects A Report prepared by ECVAM and the ECVAM Working Group on Chemicals Edited by Andrew Worth and Michael Balls
More informationOPINION "REPORT FOR ESTABLISHING THE TIMETABLE FOR PHASING OUT ANIMAL TESTING FOR THE PURPOSE OF THE COSMETICS DIRECTIVE"
THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS OPINION CONCERNING "REPORT FOR ESTABLISHING THE TIMETABLE FOR PHASING OUT ANIMAL TESTING FOR THE PURPOSE OF THE
More information11 th International Conference on Environmental Mutagens Foz du Iguaccu, Brazil; 7 November 2013
Pig-a In Vivo Mutation Assay Workgroup Report 6 th International Workshop on Genotoxicity Testing Presented By: Bhaskar Gollapudi, Ph.D. Exponent, Inc. 11 th International Conference on Environmental Mutagens
More informationComments and suggestions from reviewer
Comments and suggestions from reviewer Page 1 of 13 Title: WHO Guidelines on the Quality, Safety, and Efficacy of Biological Medicinal Products Prepared by Recombinant DNA Technology: WHO/rDNA_DRAFT/12
More informationTen Years of REACH An Animal Protection Perspective
ATLA 46, 347 373, 2018 347 Ten Years of REACH An Animal Protection Perspective Katy Taylor European Coalition to End Animal Experiments (ECEAE) and Cruelty Free International Trust, London, UK Summary
More informationCOMMISSION IMPLEMENTING DECISION. of
EUROPEAN COMMSSON Brussels, 7.9.2015 C(2015) 6030 final COMMSSON MPLEMTNG DECSON of 7.9.2015 on the evaluation of the substance polyhaloalkene pursuant to Article 46(1) of Regulation (EC) No 1907/2006
More informationThe Comet Assay How to recognise Good Data
The Comet Assay How to recognise Good Data William Barfield 4 th September 2015 ICAW Content Regulatory Genetic Toxicology JaCVAM trial overview and results Protocols Historical control data Statistics
More informationS9 Implementation Working Group ICH S9 Guideline: Nonclinical Evaluation for Anticancer Pharmaceuticals Questions and Answers
S9 Implementation Working Group ICH S9 Guideline: Nonclinical Evaluation for Anticancer Pharmaceuticals Questions and Answers Current Step 4 version International Council for Harmonisation of Technical
More informationS2(R1) Revision of the Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
S2(R1) Revision of the Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use Peter Kasper BfArM and S2(R1)EWP International Conference on Harmonisation of
More informationMAINTENANCE OF THE ICH GUIDELINE ON NON-CLINICAL SAFETY STUDIES FOR THE CONDUCT OF HUMAN CLINICAL TRIALS FOR PHARMACEUTICALS M3(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE MAINTENANCE OF THE ICH GUIDELINE ON NON-CLINICAL
More informationCOMMISSION REGULATION (EU) / of
EUROPEAN COMMISSION Brussels, 3.12.2018 C(2018) 7942 final COMMISSION REGULATION (EU) / of 3.12.2018 amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration,
More informationRisk assessment and safety compliance of nanotechnology-based products Regulatory mechanisms, guidelines and good practices
May 3, 2017 Risk assessment and safety compliance of nanotechnology-based products Regulatory mechanisms, guidelines and good practices Rawiwan Maniratanachote, Ph.D. rawiwan@nanotec.or.th National Nanotechnology
More informationNON-ANIMAL APPROACHES TO SAFETY ASSESSMENT OF COSMETIC PRODUCTS. Cutting-Edge Science and Constant Innovation: The Keys to Success
NON-ANIMAL APPROACHES TO SAFETY ASSESSMENT OF COSMETIC PRODUCTS Cutting-Edge Science and Constant Innovation: The Keys to Success 2 NON-ANIMAL APPROACHES TO SAFETY ASSESSMENT OF COSMETIC PRODUCTS Cutting-Edge
More informationAcute Dermal Toxicity Study Waiver
Regulatory Proposal PRO2017-02 Acute Dermal Toxicity Study Waiver (publié aussi en français) 1 March 2017 This document is published by the Health Canada Pest Management Regulatory Agency. For further
More informationSCCP UPDATED RECOMMENDED STRATEGY FOR TESTING OXIDATIVE HAIR DYE SUBSTANCES FOR THEIR POTENTIAL MUTAGENICITY/GENOTOXICITY
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP UPDATED RECOMMENDED
More informationRisk assessment of colourants used in cosmetics in the EU
Thomas Platzek Risk assessment of colourants used in cosmetics in the EU THOMAS PLATZEK*, RENATE KRAETKE *Corresponding author Federal Institute for Risk Assessment Berlin, D-14191, Germany ABSTRACT: Colourants
More informationMATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
More informationTypical Notification Service under China REACH
Typical Notification Service under China REACH China REACH applies to new chemical substances that are not currently listed on the Inventory of Existing Chemical Substances Produced or Imported in China
More informationDevelopments in making in vitro tests available for REACH
Integrated testing strategies for REACH 1 st SETAC Europe Special Science Symposium 1 Developments in making in vitro tests available for REACH S. Bremer, S.Casati, S. Coecke, R. Corvi, L.Gribaldo, M.Halder,
More informationCEFIC LRI Project EEM9.3
REACH INFORMATION & EXPERIENCE EXCHANGE FORUM IV 19 JUNE 2015 CEFIC LRI Project EEM9.3 Linking LRI AMBIT Chemoinformatic System with the IUCLID Substance Database to Support Read across of Substance Endpoint
More informationEURL ECVAM. A broader role for greater impact. Maurice Whelan. Head of Systems Toxicology Unit and EURL ECVAM
EURL ECVAM A broader role for greater impact Maurice Whelan Head of Systems Toxicology Unit and EURL ECVAM Institute for Health and Consumer Protection DG Joint Research Centre Meeting of the EP Intergroup
More informationName: 4-chloro-m-cresol / Legal entity owner: National Institute of Health Sciences / Kawasaki / Japan
Name: 4-chloro-m-cresol / 59-50-7 Legal entity owner: National Institute of Health Sciences / Kawasaki / Japan Printing date: 2018-03-12T13:56:15.452+09:00 i Table of Contents 4-chloro-m-cresol... 1 CORE...
More informationMATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
More informationGuidance on Information Requirements and Chemical Safety Assessment. Chapter R.7a: Endpoint specific guidance
1 GUIDANCE Guidance on Information Requirements and Chemical Safety Assessment Chapter R.7a: Endpoint specific guidance Version 3.0 August 2014 NOTE Please note that the present document is a proposed
More informationSAFETY DATA SHEET <#####> RABON 50% WETTABLE POWDER INSECTICIDE Version 1.1 Revision Date 02/20/2013
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING Product information Product Name: MSDS Number: 122000008516 Company BAYER HEALTHCARE LLC Animal Health Division 12707 Shawnee Mission
More informationTHE FUTURE OF IN VITRO SCREENING IN THE DEVELOPMENT OF NEW DRUGS. Hajime Kojima, JaCVAM, NIHS, Japan
THE FUTURE OF IN VITRO SCREENING IN THE DEVELOPMENT OF NEW DRUGS Hajime Kojima, JaCVAM, NIHS, Japan 1 3Rs of animal use (Russel and Burch 1959) Reduction (of animal use) Refinement (to lessen pain or distress
More informationMATERIAL SAFETY DATA SHEET
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
More informationIn Vitro Testing in Contract Research: A Valid Alternative? Robert Guest Head of Alternative and Acute Toxicology
In Vitro Testing in Contract Research: A Valid Alternative? Robert Guest Head of Alternative and Acute Toxicology Primary Objectives Presentation Outline Contract Research Organisations Setting the Scene
More informationCOMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 11.3.2013 COM(2013) 135 final COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the animal testing and marketing ban and on the state of play
More informationIntroduction to Adverse Outcome Pathways and the AOP Wiki
Introduction to Adverse Outcome Pathways and the AOP Wiki Sunday July 20, 2017 10:00 AM - 12:00 PM Sheraton Seattle, Aspen Room 10:00: Introduction to the OECD AOP Programme and Online Training course
More informationGuidelines and criteria for seeking approval to conduct clinical trials in Ayurveda, Siddha and Unani system.
Guidelines and criteria for seeking approval to conduct clinical trials in Ayurveda, Siddha and Unani system. Application for seeking approval of the Central Government for conduct of clinical trial in
More informationRegulatory compliance in Non-Clinical development
Regulatory compliance in Non-Clinical development SME Workshop Presented by Milton Bonelli on 3 October 2016 Clinical Pharmacology and Non-Clinical Office - Human Medicines R & D Support Division An agency
More informationCatherine Willett, Humane Society of the United States, Humane Society International
The Use of Adverse Outcome Pathways (AOPs) to Support Chemical Safety Decisions within the Context of Integrated Approaches to Testing and Assessment (IATA) Catherine Willett, Humane Society of the United
More informationOECD Environment, Health and Safety Publications Series on Testing and Assessment. No. 39 DRAFT GUIDANCE DOCUMENT ON ACUTE INHALATION TOXICITY TESTING
OECD Environment, Health and Safety Publications Series on Testing and Assessment No. 39 DRAFT GUIDANCE DOCUMENT ON ACUTE INHALATION TOXICITY TESTING Environment Directorate ORGANISATION FOR ECONOMIC CO-OPERATION
More informationFeedback from ECHA on dossier and substance evaluation
Feedback from ECHA on dossier and substance evaluation REACH Implementation Workshop X 13 December 2011 Wim De Coen ECHA Evaluation Unit I Overview Directorate of Evaluation Dossier evaluation Compliance
More informationSAFETY DATA SHEETS. This SDS packet was issued with item:
S This SDS packet was issued with item: 078909032 The safety data sheets (SDS) in this packet apply to the individual products listed below. Please refer to invoice for specific item number(s). 078909033
More information